Chinese traditional medicine composition for treating diabetic nephropathy

A technology for diabetic nephropathy and a composition is applied in the field of traditional Chinese medicine compositions for the treatment of diabetic nephropathy, which can solve the problems of difficult therapeutic action mechanism, unsatisfactory clinical efficacy and the like, and achieve the effects of large dosage of a single drug and few drug flavors.
CN1634328AInactive Publication Date: 2005-07-06魏群利
0 Cites 13 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
魏群利
Publication Date
2005-07-06
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention relates to a Chinese traditional medicine composition for treating diabetic nephropathy which comprises raw astragalus root, prepared aconite root, and prepared rhubarb, the medicine can also comprise other compositions including notoginseng, root of red rooted saliva, achyranthes and cyathula root, gen-seng, pseudostellaria root, pilose asiabell root, Poria cocos, Poria cocos.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a traditional Chinese medicine composition for treating diabetic nephropathy. Background technique

[0002] Diabetic nephropathy (DN) is the most common complication of diabetes and one of the leading causes of death in diabetic patients. With the improvement of living standards in our country, the incidence of diabetes, especially type 2 diabetes, is increasing year by year, and the incidence of DN is increasing year by year. The total incidence is as high as 40%.

[0003] The etiology and pathogenesis of DN are very complex, in addition to genetic factors, it also involves metabolism, hemodynamics, related growth factors, cytokines and many other aspects. The main pathological change of diabetic nephropathy is excessive accumulation of matrix protein in glomerular mesangial cells, followed by glomerulosclerosis and tubulointerstitial fibrosis. Studies at home and abroad have shown that transforming growth factor-β 1 (TGF-β...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More